Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer

被引：0
|
作者：
Kawabe, Nozomi [1 ]
Muraki, Nao [1 ]
Tanaka, Ichidai [2 ]
Sunaga, Noriaki [3 ]
Sato, Mitsuo [1 ]
机构：
[1] Nagoya Univ, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[3] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3031
引用
收藏
页码：1547 / 1547
页数：1
相关论文
共 50 条
  • [21] Wnt signaling as potential therapeutic target in lung cancer
    Yang, Jiali
    Chen, Juan
    He, Jinxi
    Li, Jing
    Shi, Juan
    Cho, William C.
    Liu, Xiaoming
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (08) : 999 - 1015
  • [22] An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer
    Wang, Haiyun
    Lv, Qi
    Xu, Yue
    Cai, Zhaoqing
    Zheng, Jie
    Cheng, Xiaojie
    Dai, Yao
    Janne, Pasi A.
    Ambrogio, Chiara
    Koehler, Jens
    EBIOMEDICINE, 2019, 49 : 106 - 117
  • [23] CD 146 a Potential Therapeutic Target for Lung Cancer
    Olajuyin, A.
    Olajuyin, A.
    Xingru, Z.
    Fagyuan, Q.
    Zhiti, W.
    Yasi, X.
    Zhang, X.
    Yaping, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S658 - S659
  • [24] Metabolic rewiring in mutant Kras lung cancer
    Kerr, Emma M.
    Martins, Carla P.
    FEBS JOURNAL, 2018, 285 (01) : 28 - 41
  • [25] Targeting MEK in KRAS mutant lung cancer
    Jaenne, Pasi A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [26] KRAS: A Promising Therapeutic Target for Cancer Treatment
    Wu, Hai-Zhou
    Xiao, Jia-Qi
    Xiao, Song-Shu
    Cheng, Yan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (23) : 2081 - 2097
  • [27] Therapeutic microRNA agaisnt KRAS mutant colorectal cancer
    Hiraki, Masayuki
    Nishimura, Junichi
    Uemura, Mamoru
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
    Abdel-Rahman, Omar
    JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
  • [29] KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
    Karimi, Nastaran
    Moghaddam, Seyed Javad
    CELLS, 2023, 12 (05)
  • [30] Mucin 5ac as a potential therapeutic target for KRAS-driven lung adenocarcinoma
    Torrez, Walter V. Velasco
    Deng, Shanshan
    Ramos-Castaneda, Marco A.
    Del Aguila-Soto, Segundo W.
    Moghaddam, Seyed
    CANCER RESEARCH, 2020, 80 (16)
12345